Trial Parameters
Condition Heart Failure
Sponsor Impulse Dynamics
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,500
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-11-01
Completion 2035-08-15
Brief Summary
The registry has been designed to evaluate the long-term safety and efficacy of CCM therapy in a real-world setting.
Eligibility Criteria
Inclusion Criteria: * Patients who have /will be implanted with Impulse Dynamics CCM technologies (e.g. CCM or CCM-D when available) as determined by investigators * Willing and able to provide informed consent, including for use of data for research purposes (e.g. publication, sub-studies/sub-analyses) Exclusion Criteria: * Noncompliant patients (e.g. for follow-up visits, medication, etc.) as determined by investigators. * Subjects with a mechanical tricuspid valve
Related Trials
NCT06541509
Mechanisms of Semaglutide Therapy in Heart Failure Patients
View Trial →
NCT05596253
Incidence and Predictors of Post-TIPS Heart Failure in Patients With Cirrhosis
View Trial →
NCT07343895
Population-based Atrial Fibrillation Screening in Individuals With NT-proBNP Above Median in the Tro
View Trial →